If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
24.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (13.043%)
Market Cap: £17.92m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Issue of US Patent

17 Aug 2015 07:00

RNS Number : 1406W
Altitude Group PLC
17 August 2015
 

 

ALTITUDE GROUP PLC

(the "Company")

 

Issue of US Patent

 

 

Altitude Group plc (AIM: ALT), the provider of information and technology services, announces that on 11 August 2015 a US patent was issued to Trade Only Limited, a subsidiary of the Company (the "Patent"). The Patent covers a number of claims related to the creation and rendering of artwork on to images online with the output in the correct format for web publishing or as a print ready file. In addition, the Patent covers technology designed to assist suppliers with managing inventory requirements.

 

The core technology protected by the Patent is used currently in the Artworktool.com solution. This provides the capability for users to create an artwork canvas to the correct size with a single click, based on either attributes on the page or from user inputted dimensions using any browser.

 

With a comprehensive set of tools within the solution, users can quickly and easily create print-ready artwork for any purpose and to any size, size images, change fonts, add layers and text effects.

 

Designs can be output directly to a web page to assist online sellers of personalised products, exported to be used for a Facebook cover or Twitter image, added to Google Drive or DropBox, integrated into existing ERP workflows and shared amongst friends on social media networks.

 

In addition, through seamless integration with Fotolia, users can instantly search from 30 million stock images and add to the design with a single click, or connect Facebook, Instagram and Twitter accounts to use existing images and content in new artwork creations.

 

Richard Sowerby, Executive Chairman, commented: "The grant of the US patent is the culmination of three years of work and investment in this innovative solution allowing any website publisher to fully integrate HTML5 artwork creation ability into their site. With wide ranging applications for website and email marketing publishers, print, sign and personalised gift companies as well as all the students worldwide that need to create content, Artworktool brings design and artwork creation to everyone online."

 

Vicky Robinson, Group Managing Director, said: "Our team has created an excellent solution that answers a clear market need. Alongside the many B2B applications our users can be up and running with a free account by simply logging in with a Facebook or Google+ account and they will instantly have access to all of the tools needed to create artwork for home, business, school or college."

 

Invented by Martin Varley, the Patent was issued to Trade Only Limited on 11 August 2015 with Patent No.: US 9,104,298.

 

 

Enquiries:

Altitude Group plc

Tel: 07525 220876

Richard Sowerby (Executive Chairman)

 

WH Ireland Limited (Nominated Adviser and Broker)

Tel: 0113 394 6600

Tim Feather

Liam Gribben

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABXGDIBUBBGUS
Date   Source Headline
3rd Jul 20267:00 amRNSDirectorate Changes
30th Jun 20267:00 amRNSAppointment of Non-Executive Director
18th Jun 202611:59 amRNSHolding(s) in Company
11th Jun 20267:00 amRNSDirector/PDMR Dealing
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.